經導管二尖瓣瓣膜修復術市場(金額，數量，ASP):各市場區隔規模，佔有率，趨勢及SWOT分析，法律規章及償付趨勢，手術，2033年前的預測

經導管二尖瓣修復術現已獲得 FDA 批准，用於非手術、高風險的退行性二尖瓣反流。對於有適應症的患者，二尖瓣成形術是優於二尖瓣置換術的首選治療方法，因為其短期和長期死亡率和發病率較低。由於年齡或其他醫療狀況，大約 50% 的嚴重二尖瓣反流患者不適合手術。經導管二尖瓣成形術（TMVR）用於二尖瓣反流（MR）的微創治療。

本報告提供全球經導管二尖瓣瓣膜修復術市場相關之詳細考察，提供市場上競爭情形，SWOT分析，到2033年前的市場預測，COVID-19影響，地區，各國趨勢等資訊。

目錄

現在上市的經導管二尖瓣瓣膜修復術和競爭情形

• 主要產業趨勢的洞察
• 經導管二尖瓣瓣膜修復術的各市場區隔整體市場收益和2015年～2033年的市場展望
• 各市場區隔的手術總數，台數，平均銷售價格，市場價值相關詳細資料

世界，地區，各國洞察

• 經導管二尖瓣瓣膜修復術市場SWOT分析
• 經導管二尖瓣瓣膜修復術市場相關競爭動態的洞察和趨勢
• 各國醫療制度概要
• 各國償付政策
• 各國醫療技術相關法規狀況

Abstract

Transcatheter Mitral Valve Repair Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast to 2033 is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Transcatheter Mitral Valve Repair market for the year 2020 and beyond. Transcatheter Mitral Valve Repair is currently FDA approved for non-surgical high risk degenerative mitral regurgitation. Mitral valve repair treatment is preferred over mitral valve replacement in patients who are eligible because it is linked with a lower short term and long term mortality and morbidity rates. Approximately, 50% of the severe mitral regurgitation patients are not eligible for surgery due to their age or other disorders. Transcatheter mitral valve repair (TMVR) devices are used for minimally invasive treatment of mitral regurgitation (MR).

Each of the covered 25 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Transcatheter Mitral Valve Repair (TMVR) market and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Transcatheter Mitral Valve Repair (TMVR) market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Transcatheter Mitral Valve Repair (TMVR) market.
• Competitive dynamics insights and trends provided Transcatheter Mitral Valve Repair (TMVR) market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Abbott Laboratories, Edwards Lifesciences Corp, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Japan, Australia, Canada, Mexico, Denmark, Ireland, Netherlands, New Zealand, Sweden, Switzerland, Austria, Belgium, Finland, Norway, Poland, and Portugal.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Transcatheter Mitral Valve Repair Devices marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Understand the impact of COVID-19 on Transcatheter Mitral Valve Repair market.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving Transcatheter Mitral Valve Repair market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Transcatheter Mitral Valve Repair market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Transcatheter Mitral Valve Repair market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.